This is according to the announcement from the CNIPA below today
(29 Oct 2021):
https://lnkd.in/gg7JqR_2
According to the announcement above, 23 complaints have been
filed at the CNIPA as of 27 Oct 2021, while 12 of these have been
accepted by the CNIPA (立案). These complaints
should be directed to declarations type 4.2 (please see my
Unofficial CN Orange User Guide), in which the generic suppliers
stated that their generics do no fall within the scope of the
relevant patents. The 11 refused complaints may be directed to
declarations not of the type 4.2, say 4.1?
Other than the CNIPA, the other venue to file such complaints is
the Beijing IP Court, which unfortunately has not make similar
announcements as above according to my own search (let me know if
you found it).